Literature DB >> 19995400

Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation.

Lisa-Marie Holbrook1, Nicholas A Watkins, Alan D Simmonds, Chris I Jones, Willem H Ouwehand, Jonathan M Gibbins.   

Abstract

The thiol isomerase enzymes protein disulphide isomerase (PDI) and endoplasmic reticulum protein 5 (ERp5) are released by resting and activated platelets. These re-associate with the cell surface where they modulate a range of platelet responses including adhesion, secretion and aggregation. Recent studies suggest the existence of yet uncharacterised platelet thiol isomerase proteins. This study aimed to identify which other thiol isomerase enzymes are present in human platelets. Through the use of immunoblotting, flow cytometry, cell-surface biotinylation and gene array analysis, we report the presence of five additional thiol isomerases in human and mouse platelets and megakaryocytes, namely; ERp57, ERp72, ERp44, ERp29 and TMX3. ERp72, ERp57, ERp44 and ERp29 are released by platelets and relocate to the cell surface following platelet activation. The transmembrane thiol isomerase TMX3 was also detected on the platelet surface but does not increase following activation. Extracellular PDI is also implicated in the regulation of coagulation by the modulation of tissue factor activity. ERp57 was identified within platelet-derived microparticle fractions, suggesting that ERp57 may also be involved in the regulation of coagulation as well as platelet function. These data collectively implicate the expanding family of platelet-surface thiol isomerases in the regulation of haemostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995400     DOI: 10.1111/j.1365-2141.2009.07994.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  45 in total

1.  The disulfide isomerase ERp57 is required for fibrin deposition in vivo.

Authors:  J Zhou; Y Wu; L Wang; L Rauova; V M Hayes; M Poncz; D W Essex
Journal:  J Thromb Haemost       Date:  2014-09-26       Impact factor: 5.824

2.  Osteoblastic cell secretome: a novel role for progranulin during risedronate treatment.

Authors:  Milena Romanello; Elzbieta Piatkowska; Giulia Antoniali; Laura Cesaratto; Carlo Vascotto; Renato V Iozzo; Daniela Delneri; Francesco L Brancia
Journal:  Bone       Date:  2013-10-11       Impact factor: 4.398

Review 3.  Vascular thiol isomerases.

Authors:  Robert Flaumenhaft; Bruce Furie
Journal:  Blood       Date:  2016-06-29       Impact factor: 22.113

4.  Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.

Authors:  Michael C Yi; Arek V Melkonian; James A Ousey; Chaitan Khosla
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

5.  Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.

Authors:  Yicong Li; Anthonya Cooper; Imelda N Odibo; Asli Ahmed; Pamela Murphy; Ruston Koonce; Nafisa K Dajani; Curtis L Lowery; Drucilla J Roberts; Luc Maroteaux; Fusun Kilic
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

Review 6.  Protein disulfide isomerase in thrombosis and vascular inflammation.

Authors:  J Cho
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

Review 7.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

Review 8.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

9.  An arsenical-maleimide for the generation of new targeted biochemical reagents.

Authors:  Aparna Sapra; Colin Thorpe
Journal:  J Am Chem Soc       Date:  2013-02-08       Impact factor: 15.419

Review 10.  Regulatory role of thiol isomerases in thrombus formation.

Authors:  Anish Sharda; Bruce Furie
Journal:  Expert Rev Hematol       Date:  2018-03-28       Impact factor: 2.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.